Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
3.740
+0.140 (3.89%)
Nov 13, 2025, 4:10 PM AEST
3.89%
Market Cap590.86M
Revenue (ttm)28.00K
Net Income (ttm)-16.41M
Shares Out157.98M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume737,492
Average Volume1,073,761
Open3.760
Previous Close3.600
Day's Range3.610 - 3.870
52-Week Range0.410 - 4.020
Beta0.62
RSI63.12
Earnings DateOct 28, 2025

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.